[account_shop_links]
CDMOs
Showing 1–12 of 21 resultsSorted by latest
CDMO Market Analysis & Service Provider Benchmarking
With biologics and complex small molecules driving the next wave of drug development, the Contract Development and Manufacturing Organization (CDMO) landscape is shifting toward specialized, high-potency, and large-molecule expertise. ISR’s CDMO market research tracks these shifts, offering deep dives into outsourcing models, capacity trends, and customer loyalty. Whether you are navigating the “build vs. buy” decision or evaluating API manufacturing partners, our data provides the objective clarity needed for strategic supply chain decisions.












